Ionis Pharmaceuticals (IONS) net assets (shareholders' equity)

Net assets · fiscal 2025
$489.09M

Ionis Pharmaceuticals (IONS) had net assets of $489.09M at the end of fiscal 2025 (December 31, 2025). That is 16.9% lower than the $588.35M of fiscal 2024. Figures as of 19 Nov 2026, 03:14 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$489.09M
Change on fiscal 2024
−16.9%
Growth, 5 years
−8.0% a year
Growth, 10 years
+9.3% a year
Highest on record
$1.47Bfiscal 2019
Lowest on record
$99.57Mfiscal 2016
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Ionis Pharmaceuticals net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets shrank at a compound 8.0% a year; over ten years the rate was 9.3% a year. Across the 18 fiscal years on record (2008–2025), the highest was $1.47B in fiscal 2019 and the lowest $99.57M in fiscal 2016.

History · 18 fiscal years

Net assets by fiscal year

Ionis Pharmaceuticals net assets (shareholders' equity), year by year

Ionis Pharmaceuticals (IONS) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$489.09M 16.9% down
2024$588.35M 52.2% up
2023$386.69M 32.5% down
2022$572.89M 25.8% down
2021$771.74M 3.8% up
2020$743.28M 49.5% down
2019$1.47B 40.4% up
2018$1.05B 273.0% up
2017$281.01M 182.2% up
2016$99.57M 50.4% down
2015$200.79M 22.1% down
2014$257.78M 31.9% down
2013$378.39M 107.0% up
2012$182.77M 6.6% up
2011$171.43M 29.9% down
2010$244.54M 16.2% down
2009$291.72M 97.9% up
2008$147.38M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Ionis Pharmaceuticals and comparable companies
CompanyNet assetsFiscal year
Edgewise Therapeutics EWTX$522.26M2025
LivaNova LIVN$1.20B2025
Ionis Pharmaceuticals IONS$489.09M2025
Dianthus Therapeutics DNTH$493.40M2025
MiniMed Group MMED$3.61B2026
Adaptive Biotechnologies ADPT$218.79M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on IONS

Ionis Pharmaceuticals, figure by figure

Ionis Pharmaceuticals (IONS) overview: price, valuation and scorecardAll health care companies by market value

Ionis Pharmaceuticals net assets (shareholders' equity): questions and answers

What are Ionis Pharmaceuticals's net assets?

Ionis Pharmaceuticals (IONS) had net assets of $489.09M at the end of fiscal 2025 (December 31, 2025). That is 16.9% lower than the $588.35M of fiscal 2024.

What is the growth rate of Ionis Pharmaceuticals's net assets?

Over the five fiscal years to 2025 net assets shrank at a compound 8.0% a year; over ten years the rate was 9.3% a year.

What are the highest and lowest net assets figures on record for Ionis Pharmaceuticals?

Across the 18 fiscal years on record (2008–2025), the highest was $1.47B in fiscal 2019 and the lowest $99.57M in fiscal 2016.

How is Ionis Pharmaceuticals's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Ionis Pharmaceuticals it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Ionis Pharmaceuticals (IONS) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/IONS/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.